Influence of Closed Suction Drainage After Total Knee Replacement.
TKR
1 other identifier
interventional
100
0 countries
N/A
Brief Summary
The aim of the study will be to compare functional outcomes, basic morphology results, number of blood transfusions, costs of hospitalization, and inflammation factors, following total knee replacement (with use of one type of endoprosthesis) comparing use of closed suction drainage (CSD). Use of closed suction drainage may have influence on patients functional outcome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2022
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 25, 2019
CompletedFirst Posted
Study publicly available on registry
June 21, 2019
CompletedStudy Start
First participant enrolled
March 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 2, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2023
CompletedOctober 6, 2021
October 1, 2021
8 months
April 25, 2019
October 5, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Change in haematocrite levels
Measuring results of haematocrite (in percentage in 1 ml of blood sample)
from baseline (can be measured anytime to a maximum of one month before surgery) to 1-day, 3,6 and 12 months post-operatively
Change in the number of blood transfusions
Measuring the number of needed transfusion of packed red blood cells in the postoperative period
from baseline to the 1-,2-,3- days postoperatively
Change in levels of inflammation factors
Measuring the level of C-reactive protein
from baseline (can be measured anytime to a maximum of one month before surgery) to 1-day, 3,6 and 12 months post-operatively
Change in haemoglobin levels
Measuring results of haemoglobin (g/dL)
from baseline (can be measured anytime to a maximum of one month before surgery) to 1-day, 3,6 and 12 months post-operatively
Change in erythrocytes levels
Measuring results of erythrocytes (number/ml)
from baseline (can be measured anytime to a maximum of one month before surgery) to 1-day, 3,6 and 12 months post-operatively
Change in platelets levels
Measuring results of platelets (number/ml)
from baseline (can be measured anytime to a maximum of one month before surgery) to 1-day, 3,6 and 12 months post-operatively
Secondary Outcomes (4)
Change in Western Ontario and McMasters University Osteoarthritis Index (WOMAC) Pain Score from baseline
from baseline (can be measured anytime to a maximum of one month before surgery) 3,6 and 12 months post-operatively
Change in Western Ontario and McMasters University Osteoarthritis Index (WOMAC) Function Score from baseline
from baseline (can be measured anytime to a maximum of one month before surgery) 3,6 and 12 months post-operatively
Change in body temperature
from baseline to the 1-,2-,3- days postoperatively
Influence of using CSD on costs of hospitalization
from baseline to the one year postoperatively
Study Arms (2)
Total knee replacement with use of closed suction drainage
ACTIVE COMPARATORUse of closed suction drainage following total knee replacement in treatment of knee primary osteoarthritis
Total knee replacement without use of closed suction drainage
ACTIVE COMPARATORWithout the use of closed suction drainage following total knee replacement in treatment of knee primary osteoarthritis
Interventions
Use of closed suction drainage following total knee arthroplasty
Abstain of using a closed suction drainage following total knee arthroplasty
Eligibility Criteria
You may qualify if:
- patient's consent for anticipation in the study
- arthroplasty in one knee
You may not qualify if:
- patient's lack of consent for anticipation in the study
- haematological diseases
- reoperations in the area of endoprosthesis
- medical history of any surgical intervention on the lower limb
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Artur Stolarczyk, MD, PhD
Medical University of Warsaw
- PRINCIPAL INVESTIGATOR
Marcin Wojewodzki
Medical University of Warsaw
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of the Department of Orthopaedics and Rehabilitation, Principal Investigator, Clinical Professor
Study Record Dates
First Submitted
April 25, 2019
First Posted
June 21, 2019
Study Start
March 1, 2022
Primary Completion
November 2, 2022
Study Completion
March 1, 2023
Last Updated
October 6, 2021
Record last verified: 2021-10
Data Sharing
- IPD Sharing
- Will not share